Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Nephropathy”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT00626249
What this trial is testing

Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

Who this might be right for
Mild NephropathyModerate NephropathyDiabetes Mellitus
Mannkind Corporation 36
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT02199379
What this trial is testing

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

Who this might be right for
Renal ImpairmentDisease Severity
Eisai Inc. 26
Post-approval studies (Phase 4)Study completedNCT03123406
What this trial is testing

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Kyowa Kirin China Pharmaceutical Co., Ltd. 750
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Early research (Phase 1)Study completedNCT05940402
What this trial is testing

Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function

Who this might be right for
Renal Impairment
AbbVie 58
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Early research (Phase 1)Study completedNCT01120314
What this trial is testing

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment

Who this might be right for
Renal Impairment
Sanofi 48
Early research (Phase 1)Study completedNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 35
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Early research (Phase 1)Study completedNCT00418366
What this trial is testing

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Who this might be right for
Renal InsufficiencyHemodialysis
Merck Sharp & Dohme LLC 24
Not applicableStudy completedNCT07370662
What this trial is testing

Effect of Resistance Exercises and Relaxation Therapy on Physical Function and Quality Of Life in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)
Rashid Latif Medical College 50
Early research (Phase 1)Study completedNCT06747520
What this trial is testing

Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Who this might be right for
Renal Insufficiency
Ahon Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT01934166
What this trial is testing

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
H. Lundbeck A/S 32
Early research (Phase 1)Study completedNCT05491642
What this trial is testing

A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses

Who this might be right for
Chronic Kidney DiseaseHypertension
Bayer 56
Early research (Phase 1)Looking for participantsNCT07001436
What this trial is testing

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects

Who this might be right for
Renal Insufficiency
Henan Genuine Biotech Co., Ltd. 40
Next Page